Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

AAIC 2022

What's new?

View all
8:12
EXERT results: exercise shown to stall cognitive decline in patients with mild cognitive impairment
Laura Baker • 26 Jul 2022
4:58
Screening for delirium in individuals with dementia
Sharon K. Inouye • 2 Aug 2022
4:27
High intake of ultra-processed food associated with cognitive decline
Natalia Gonçalves • 10 Aug 2022
6:32
Blood biomarkers in Alzheimer’s disease: appropriate use recommendations
Stephen Salloway • 19 Aug 2022

Trial Updates

View all
6:17
Preliminary results from the Phase II PIONEER trial of T3D-959 in mild-moderate Alzheimer’s disease
John Didsbury • 8 Aug 2022
4:23
Successful Aging after Elective Surgery: goals of the SAGES II study
Sharon K. Inouye • 2 Aug 2022
7:44
Clinical trial assessing a multi-nutrient drink in age-related cognitive decline
Christian J. Camargo • 17 Aug 2022
5:03
PASTIS: investigating the impact of tadalafil on cerebral blood flow in small vessel disease
Atticus Hainsworth • 16 Aug 2022

Latest findings in biomarkers

View all
3:19
Prognostic blood biomarkers in the pre-clinical stages of Alzheimer’s disease
Marta Milà-Alomà • 12 Aug 2022
10:02
Blood biomarkers in AD: latest data, establishing SOPs, and new appropriate use guidelines
Charlotte Teunissen • 10 Aug 2022

Novel therapeutic strategies

View all
2:35
Lifestyle intervention strategies in Alzheimer’s disease
James Galvin • 12 Aug 2022
3:23
Buntanetap mechanism of action
Cheng Fang • 19 Aug 2022
The content of VJDementia is intended for healthcare professionals